Sana Biotechnology (SANA) Announces CFO Resignation

On September 6, 2024, Nathan Hardy notified Sana Biotechnology (NASDAQ: SANA) that he intends to resign from his position as Executive Vice President and Chief Financial Officer of the Company effective October 4, 2024. Mr. Hardy resigned voluntarily for personal reasons and not as a result of any disagreement with the Company on any matter, including related to the Company’s operations, policies, practices or otherwise.

You May Also Be Interested In

• Lowe's names five executive vice presidents effective Sept. 1
• HPE expands networking deal with Oracle for AI data centers
• JPMorgan reduced lending to Jane Street over bond market competition - FT